Short Interest in Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Decreases By 13.6%
MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 5,290,000 shares, a decline of 13.6% from the April 30th total of 6,120,000 shares. Based on an average daily volume of 1,250,000 shares, the days-to-cover ratio is currently 4.2 days. Currently, 9.4% of the company's stock are short sold.
NASDAQ:PTGX